Marco Schäferhoff

Open Consultants

Managing Director

Cantianstr. 22

Berlin, Berlin 10437

Germany

SCHOLARLY PAPERS

4

DOWNLOADS

858

SSRN CITATIONS

3

CROSSREF CITATIONS

1

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Funding the Development and Manufacturing of COVID-19 Vaccines

Background paper for the World Bank/CEPI financing COVID-19 vaccine development consultation on February 20, 2020. The Center for Policy Impact in Global Health., Duke Global Working Paper Series No. 20, March 2020
Number of pages: 27 Posted: 14 Apr 2020
Gavin Yamey, Marco Schäferhoff, Muhammad Pate, Mukesh Chawla, Kent Ranson, Richard Hatchett and Richard Wilder
Duke Global Health Institute, Open Consultants, World Bank, Harvard University - T.H. Chan School of Public Health, World Bank - Geneva, Coalition for Epidemic Preparedness Innovations and Coalition for Epidemic Preparedness Innovations
Downloads 409 (124,434)
Citation 5

Abstract:

Loading...

COVID-19, pandemic, vaccine, infectious diseases, research and development, clinical trials

2.

Transitioning Away from Donor Funding for Health: A Cross Cutting Examination of Donor Approaches to Transition

The Center for Policy Impact in Global Health., Duke Global Working Paper Series No. 21, April 2020
Number of pages: 28 Posted: 21 Apr 2020
Kaci Kennedy McDade, Marco Schäferhoff, Osondu Ogbuoji, Ipchita Bharali, Siddharth Dixit, Wenhui Mao, Shashika Bandara and Gavin Yamey
Center for Policy Impact in Global Health, Duke University, Open Consultants, Duke University, Duke University - Duke Global Health Institute, Duke University - Duke Global Health Institute, Duke University - Duke Global Health Institute, McGill University and Duke Global Health Institute
Downloads 180 (284,502)
Citation 4

Abstract:

Loading...

Transition, graduation, foreign aid, health aid, development assistance for health, aid for health, multilateral donor, bilateral donor, the World Bank, USAID, PEPFAR, DFID, JICA

3.

Developing an Aggregator Mechanism for Late-Stage Clinical Trials of Neglected Disease Product Candidates

Duke Global Working Paper Series No. 23
Number of pages: 98 Posted: 21 Oct 2020
Gavin Yamey, Marco Schäferhoff, Mary Moran, Mohamed Mustafa Diab, Kaci Kennedy McDade, Wenhui Mao, Parth Chodavadia, Armand Zimmerman, Vipul Chowdhary, Robert Karanja, Mziwandile Madikizela and Osondu Ogbuoji
Duke Global Health Institute, Open Consultants, Duke University, Center for International and Global Studies, Center for Policy Impact in Global Health, Center for Policy Impact in Global Health, Duke University, Duke University - Duke Global Health Institute, Duke Global Health Institute, Duke University - Duke Global Health Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Duke University
Downloads 143 (345,152)
Citation 3

Abstract:

Loading...

poverty-related and neglected diseases (PRNDs), aggregator mechanism, research and development, clinical trials, antimicrobial resistance, infectious diseases, Covid-19, AIDS, tuberculosis, malaria, public funding for R&D, vaccine, public health

4.

Investing in Late-Stage Clinical Trials and Manufacturing of Neglected Disease Product Candidates – Modeling the Benefits and Costs of Investments for Three Middle-Income Countries

Number of pages: 92 Posted: 13 Aug 2021
Marco Schäferhoff, Armand Zimmerman, Mohamed Mustafa Diab, Wenhui Mao, Vipul Chowdhary, Davinder Gill, Robert Karanja, Mziwandile Madikizela, Osondu Ogbuoji and Gavin Yamey
Open Consultants, Duke University - Duke Global Health Institute, Center for Policy Impact in Global Health, Duke University - Duke Global Health Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Duke University and Duke Global Health Institute
Downloads 126 (380,321)

Abstract:

Loading...